Growth Metrics

AC Immune (ACIU) Share-based Compensation (2016 - 2025)

AC Immune has reported Share-based Compensation over the past 10 years, most recently at $1.1 million for Q4 2025.

  • Quarterly Share-based Compensation rose 2.46% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Dec 2025, down 15.82% year-over-year, with the annual reading at $5.5 million for FY2025, 11.91% down from the prior year.
  • Share-based Compensation was $1.1 million for Q4 2025 at AC Immune, up from $1.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $2.2 million in Q1 2024 and troughed at $574678.4 in Q3 2022.
  • The 5-year median for Share-based Compensation is $1.1 million (2024), against an average of $1.2 million.
  • Year-over-year, Share-based Compensation crashed 61.96% in 2022 and then surged 70.8% in 2023.
  • A 5-year view of Share-based Compensation shows it stood at $1.1 million in 2021, then fell by 18.57% to $922801.5 in 2022, then decreased by 2.63% to $898501.5 in 2023, then increased by 22.85% to $1.1 million in 2024, then grew by 2.46% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Share-based Compensation are $1.1 million (Q4 2025), $1.0 million (Q3 2025), and $1.4 million (Q2 2025).